1. Home
  2. PHAR vs ASTE Comparison

PHAR vs ASTE Comparison

Compare PHAR & ASTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHAR
  • ASTE
  • Stock Information
  • Founded
  • PHAR 1988
  • ASTE 1972
  • Country
  • PHAR Netherlands
  • ASTE United States
  • Employees
  • PHAR N/A
  • ASTE N/A
  • Industry
  • PHAR Biotechnology: Pharmaceutical Preparations
  • ASTE Construction/Ag Equipment/Trucks
  • Sector
  • PHAR Health Care
  • ASTE Industrials
  • Exchange
  • PHAR Nasdaq
  • ASTE Nasdaq
  • Market Cap
  • PHAR 718.1M
  • ASTE 777.8M
  • IPO Year
  • PHAR N/A
  • ASTE N/A
  • Fundamental
  • Price
  • PHAR $11.24
  • ASTE $38.97
  • Analyst Decision
  • PHAR Strong Buy
  • ASTE Hold
  • Analyst Count
  • PHAR 3
  • ASTE 1
  • Target Price
  • PHAR $30.00
  • ASTE $41.00
  • AVG Volume (30 Days)
  • PHAR 3.1K
  • ASTE 132.8K
  • Earning Date
  • PHAR 05-08-2025
  • ASTE 04-29-2025
  • Dividend Yield
  • PHAR N/A
  • ASTE 1.32%
  • EPS Growth
  • PHAR N/A
  • ASTE N/A
  • EPS
  • PHAR N/A
  • ASTE 0.66
  • Revenue
  • PHAR $320,708,000.00
  • ASTE $1,325,300,000.00
  • Revenue This Year
  • PHAR $13.31
  • ASTE $5.51
  • Revenue Next Year
  • PHAR $7.68
  • ASTE $3.99
  • P/E Ratio
  • PHAR N/A
  • ASTE $59.31
  • Revenue Growth
  • PHAR 24.13
  • ASTE 1.99
  • 52 Week Low
  • PHAR $6.65
  • ASTE $28.46
  • 52 Week High
  • PHAR $11.07
  • ASTE $42.79
  • Technical
  • Relative Strength Index (RSI)
  • PHAR 69.87
  • ASTE 49.44
  • Support Level
  • PHAR $10.02
  • ASTE $38.86
  • Resistance Level
  • PHAR $10.89
  • ASTE $40.42
  • Average True Range (ATR)
  • PHAR 0.23
  • ASTE 0.82
  • MACD
  • PHAR 0.11
  • ASTE -0.43
  • Stochastic Oscillator
  • PHAR 100.00
  • ASTE 9.75

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About ASTE Astec Industries Inc.

Astec Industries Inc designs and manufactures equipment and components used in road construction and other development activities. Its products are used through the entire process of building roads, from mining and crushing materials to creating the road surface. The company manufactures a line of plants, pavers, vehicles, and machines to mix and transform materials into construction components. It has two operating segments: infrastructure solutions generating maximum revenue and materials solutions. The majority of sales are derived from the United States. Its customers are asphalt producers, highway and heavy equipment contractors, ready mix concrete producers, demolition recycling markets, sand and gravel producers, open mine operators, quarry operators, and others.

Share on Social Networks: